RETTINGER, Eva, MEYER, Vida, KREYENBERG, Hermann, VOLK, Andreas, KUÇI, Selim, WILLASCH, Andre Manfred, KOSCIELNIAK, Ewa, FULDA, Simone, WELS, Winfried S., BÖNIG, Halvard, KLINGEBIEL, Thomas und BADER, Peter, 2012. Cytotoxic capacity of IL-15-stimulated cytokine-induced killer cells against human acute myeloid leukemia and rhabdomyosarcoma in humanized preclinical mouse models. Frontiers in oncology. 2012. No. Band 2, Heft 32 (2012), p. , Heft 32 (2012). DOI 10.3389/fonc.2012.00032.

Rettinger, E., Meyer, V., Kreyenberg, H., Volk, A., Kuçi, S., Willasch, A.M., Koscielniak, E., Fulda, S., Wels, W.S., Bönig, H., Klingebiel, T., Bader, P., 2012. Cytotoxic capacity of IL-15-stimulated cytokine-induced killer cells against human acute myeloid leukemia and rhabdomyosarcoma in humanized preclinical mouse models. Frontiers in oncology , Heft 32 (2012). https://doi.org/10.3389/fonc.2012.00032

Rettinger, E., Meyer, V., Kreyenberg, H., Volk, A., Kuçi, S., Willasch, A. M., Koscielniak, E., Fulda, S., Wels, W. S., Bönig, H., Klingebiel, T., & Bader, P. (ca. 2012). Cytotoxic capacity of IL-15-stimulated cytokine-induced killer cells against human acute myeloid leukemia and rhabdomyosarcoma in humanized preclinical mouse models [Electronic]. Frontiers in oncology, Band 2, Heft 32 (2012), , Heft 32 (2012). https://doi.org/10.3389/fonc.2012.00032

Rettinger E, Meyer V, Kreyenberg H, Volk A, Kuçi S, Willasch AM, Koscielniak E, Fulda S, Wels WS, Bönig H, Klingebiel T, Bader P (2012) Cytotoxic capacity of IL-15-stimulated cytokine-induced killer cells against human acute myeloid leukemia and rhabdomyosarcoma in humanized preclinical mouse models. Frontiers in oncology , Heft 32 (2012). https://doi.org/10.3389/fonc.2012.00032

Rettinger, Eva/ Meyer, Vida/ Kreyenberg, Hermann/ Volk, Andreas/ Kuçi, Selim/ Willasch, Andre Manfred/ Koscielniak, Ewa/ Fulda, Simone/ Wels, Winfried S./ Bönig, Halvard/ Klingebiel, Thomas/ Bader, Peter, Cytotoxic capacity of IL-15-stimulated cytokine-induced killer cells against human acute myeloid leukemia and rhabdomyosarcoma in humanized preclinical mouse models, Frontiers in oncology 2012, , Heft 32 (2012).